101
|
Abbasi R, Abdou Y, Abu-Zayyad T, Adams J, Aguilar JA, Ahlers M, Andeen K, Auffenberg J, Bai X, Baker M, Barwick SW, Bay R, Bazo Alba JL, Beattie K, Beatty JJ, Bechet S, Becker JK, Becker KH, Benabderrahmane ML, BenZvi S, Berdermann J, Berghaus P, Berley D, Bernardini E, Bertrand D, Besson DZ, Bindig D, Bissok M, Blaufuss E, Blumenthal J, Boersma DJ, Bohm C, Bose D, Böser S, Botner O, Braun J, Brown AM, Buitink S, Carson M, Chirkin D, Christy B, Clem J, Clevermann F, Cohen S, Colnard C, Cowen DF, D'Agostino MV, Danninger M, Daughhetee J, Davis JC, De Clercq C, Demirörs L, Depaepe O, Descamps F, Desiati P, de Vries-Uiterweerd G, DeYoung T, Díaz-Vélez JC, Dierckxsens M, Dreyer J, Dumm JP, Ehrlich R, Eisch J, Ellsworth RW, Engdegård O, Euler S, Evenson PA, Fadiran O, Fazely AR, Fedynitch A, Feusels T, Filimonov K, Finley C, Fischer-Wasels T, Foerster MM, Fox BD, Franckowiak A, Franke R, Gaisser TK, Gallagher J, Geisler M, Gerhardt L, Gladstone L, Glüsenkamp T, Goldschmidt A, Goodman JA, Grant D, Griesel T, Gross A, Grullon S, Gurtner M, Ha C, Hallgren A, Halzen F, Han K, Hanson K, Heinen D, Helbing K, Herquet P, Hickford S, Hill GC, Hoffman KD, Homeier A, Hoshina K, Hubert D, Huelsnitz W, Hülss JP, Hulth PO, Hultqvist K, Hussain S, Ishihara A, Jacobsen J, Japaridze GS, Johansson H, Joseph JM, Kampert KH, Kappes A, Karg T, Karle A, Kelley JL, Kemming N, Kenny P, Kiryluk J, Kislat F, Klein SR, Köhne JH, Kohnen G, Kolanoski H, Köpke L, Kopper S, Koskinen DJ, Kowalski M, Kowarik T, Krasberg M, Krings T, Kroll G, Kuehn K, Kuwabara T, Labare M, Lafebre S, Laihem K, Landsman H, Larson MJ, Lauer R, Lehmann R, Lünemann J, Madsen J, Majumdar P, Marotta A, Maruyama R, Mase K, Matis HS, Meagher K, Merck M, Mészáros P, Meures T, Middell E, Milke N, Miller J, Montaruli T, Morse R, Movit SM, Nahnhauer R, Nam JW, Naumann U, Niessen P, Nygren DR, Odrowski S, Olivas A, Olivo M, O'Murchadha A, Ono M, Panknin S, Paul L, Pérez de los Heros C, Petrovic J, Piegsa A, Pieloth D, Porrata R, Posselt J, Price PB, Prikockis M, Przybylski GT, Rawlins K, Redl P, Resconi E, Rhode W, Ribordy M, Rizzo A, Rodrigues JP, Roth P, Rothmaier F, Rott C, Ruhe T, Rutledge D, Ruzybayev B, Ryckbosch D, Sander HG, Santander M, Sarkar S, Schatto K, Schmidt T, Schoenwald A, Schukraft A, Schultes A, Schulz O, Schunck M, Seckel D, Semburg B, Seo SH, Sestayo Y, Seunarine S, Silvestri A, Slipak A, Spiczak GM, Spiering C, Stamatikos M, Stanev T, Stephens G, Stezelberger T, Stokstad RG, Stoyanov S, Strahler EA, Straszheim T, Sullivan GW, Swillens Q, Taavola H, Taboada I, Tamburro A, Tarasova O, Tepe A, Ter-Antonyan S, Tilav S, Toale PA, Toscano S, Tosi D, Turčan D, van Eijndhoven N, Vandenbroucke J, Van Overloop A, van Santen J, Vehring M, Voge M, Voigt B, Walck C, Waldenmaier T, Wallraff M, Walter M, Weaver C, Wendt C, Westerhoff S, Whitehorn N, Wiebe K, Wiebusch CH, Williams DR, Wischnewski R, Wissing H, Wolf M, Woschnagg K, Xu C, Xu XW, Yodh G, Yoshida S, Zarzhitsky P. Limits on neutrino emission from gamma-ray bursts with the 40 string IceCube detector. PHYSICAL REVIEW LETTERS 2011; 106:141101. [PMID: 21561178 DOI: 10.1103/physrevlett.106.141101] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/07/2011] [Indexed: 05/30/2023]
Abstract
IceCube has become the first neutrino telescope with a sensitivity below the TeV neutrino flux predicted from gamma-ray bursts if gamma-ray bursts are responsible for the observed cosmic-ray flux above 10(18) eV. Two separate analyses using the half-complete IceCube detector, one a dedicated search for neutrinos from pγ interactions in the prompt phase of the gamma-ray burst fireball and the other a generic search for any neutrino emission from these sources over a wide range of energies and emission times, produced no evidence for neutrino emission, excluding prevailing models at 90% confidence.
Collapse
|
102
|
Paul L, Aviv A, Vasan RS, D'Agostino RB, Levy D, Jacques PF, Selhub J. Modulation of telomere length by the C677T polymorphism of the MTHFR gene and plasma folate status. FASEB J 2011. [DOI: 10.1096/fasebj.25.1_supplement.782.12] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
103
|
Thurston S, Paul L, Loney P, Ye C, Wong M, Browne G. Associations and costs of parental symptoms of psychiatric distress in a multi-diagnosis group of children with special needs. JOURNAL OF INTELLECTUAL DISABILITY RESEARCH : JIDR 2011; 55:263-280. [PMID: 21199042 DOI: 10.1111/j.1365-2788.2010.01356.x] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
BACKGROUND Families supporting children with complex needs are significantly more distressed and economically disadvantaged than families of children without disability and delay. What is not known is the associations and costs of parental psychiatric distress within a multi-diagnosis group of special needs children. METHODS In this cross-sectional survey, families were identified from the Children's Treatment Network. Families were eligible if the child was aged 0-19 years, resided in Simcoe/York, and if there were multiple family needs (n = 429). RESULTS Some 42% of surveyed parents exhibited symptoms (mild to severe) of psychiatric distress. The presence of these symptoms was associated with reports of poorer social support, family dysfunction, greater adverse impact of the child's situation on the family, poorer child behaviour, unfavourable parenting styles and poorer child psychosocial functioning. The severity of the child's physical dysfunction was not related to parents/guardians most knowledgeable symptoms of psychiatric distress. Total parent costs were higher and children's uses of primary care services were higher in parents with symptoms of psychiatric distress. CONCLUSION Parent symptoms of psychiatric distress are a significant societal concern in families with complex needs children. Children's rehabilitation efforts need to incorporate parental mental health assessment and treatment into existing programmes. This could lead to decreases in direct and indirect healthcare utilisation costs.
Collapse
|
104
|
Mocumbi AO, Paul L, Maciel L, Silvia P, Ferreira MB. Secondary intracardiac Burkitt-like lymphoma in the absence of HIV infection. Cardiovasc J Afr 2011; 22:96-97. [PMID: 21556454] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2023] Open
Abstract
Malignant lymphoma can involve the cardiac cavity or myocardium as a mass. Since clinical symptoms of its cardiac involvement are usually absent or non-specific, they may be undetected during life. Burkitt-like lymphoma (BLL) is a highly aggressive B-cell lymphoma with a high proliferative rate. Histopathological characteristics are considered borderline between those of classic Burkitt lymphoma and diffuse large B-cell lymphoma. Extensive cardiac involvement of BLL is rare and poorly documented in the literature. We report the case of a child with BLL, presenting with extensive infiltration of the heart in the absence of HIV infection, and with right-sided heart failure and positional dyspnoea as the major clinical problems. We highlight the challenges for diagnosis and adequate treatment in poor settings like ours.
Collapse
|
105
|
Parada JA, Arumugam A, Agullo P, Myers S, Delgado A, Boopalan T, Lakshmanaswamy R, Paul L. Abstract P1-08-02: Short-Term Pregnancy Levels of Estradiol Delays Mammary Tumor Development by Altering PI3K/AKT Pathway in Her2/neu Mice. Cancer Res 2010. [DOI: 10.1158/0008-5472.sabcs10-p1-08-02] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Approximately 20-30% of all breast cancers overexpress the human epithelial growth factor receptor 2 (Her2). Breast cancers that overexpress Her2 have been associated with a more aggressive phenotype and decreased survival. Currently, the FDA has only approved trastuzumab, a recombinant monoclonal antibody against the Her2 receptor, for treatment of Her2- overexpressing breast cancer. Even though trastuzumab has been effective, many breast cancers do not respond to treatment or they eventually progress to a resistant state. Hence, several research investigations are underway to identify therapies besides trastuzumab that could be used for the treatment of Her2-positive breast cancer. It has been earlier demonstrated that uniparous Her2/neu transgenic mice developed smaller mammary tumors and these tumors had significantly decreased metastatic potential. Also, we had earlier demonstrated that short-term treatment with pregnancy levels of estradiol was very effective in delaying tumor progression and decreasing tumor burden. In this present investigation, we have attempted to understand the molecular mechanisms underlying this anti-tumor effect of short-term pregnancy levels of estradiol treatment against Her2/neu driven mammary carcinogenesis. Seven week old activated Her2/neu (murine-mammary-tumor virus (MMTV)-c-neu) FVB transgenic mice were treated for 3 weeks with 100mg of estradiol in silastic capsules. We have shown that this dose of estradiol treatment mimics pregnancy levels of the hormone in circulation. Control animals received empty silastic capsules for the same duration. Mice were palpated once every week for nine months to monitor the development of mammary cancer. Histopathological examination was performed to confirm the carcinomatous nature of the palpable tumors. A group (n=3) of mice were terminated from control and estradiol treated groups immediately after three weeks of treatment, and also, at 6 and 12 weeks post withdrawal of the treatment. Mammary tumor and normal mammary tissue were excised, snap-frozen in liquid nitrogen and stored at −80°C. Protein and total RNA were extracted from these tissues. Pathway focused microarray analysis was done on the PI3K/AKT pathway. Results demonstrate that, in parous and estrogen treated mice, proteins and genes involved in tumor-suppression (Mtcp1,Rbl2,Srf and Ywhah) and immune response (Cd14,Tlr4) were upregulated; which have been shown to play a role in reducing tumors by induction of apoptosis. This trend in gene expression alteration is present in both normal and mammary tumor tissue in the estradiol treated and parous groups and demonstrates that short-term pregnancy levels estrogen is altering the PI3K/AKT pathway; which correlates with our previous findings that short-term estradiol treatment is effective in tumor delay.
Citation Information: Cancer Res 2010;70(24 Suppl):Abstract nr P1-08-02.
Collapse
|
106
|
Delgado A, Boopalan T, Arumugam A, Agullo P, Parada J, Lakshmanaswamy R, Paul L. Abstract P1-08-01: Short-Term Exposure to Pregnancy Levels of Estrogen Alters Key Molecular Pathways Involved in Breast Cancer Development. Cancer Res 2010. [DOI: 10.1158/0008-5472.sabcs10-p1-08-01] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Breast cancer is the most common cancer in women worldwide and attempts at prevention of breast cancer are important areas of clinical and experimental investigations. Interestingly, a full-term pregnancy before the age of twenty is the only natural phenomenon known that can drastically reduce the risk of breast cancer in women. The universal protective effect of early pregnancy is clearly a major consideration in devising breast cancer prevention strategies. Rats that have been exposed to carcinogens before or after undergoing a full-term pregnancy are protected from mammary carcinogenesis. Hormonal prevention strategies have used exogenous hormonal treatment to mimic the protective effect of early full-term pregnancy against breast cancer. We have demonstrated that short-term treatment with pregnancy levels of estradiol with or without progesterone is highly effective in conferring protection against mammary carcinogenesis in rats. In order to understand the molecular mechanism of the protective effect of short-term pregnancy levels of estradiol treatment we have performed pathway focused microarrays. Nine week old female Lewis rats were divided into three groups, each consisting of 15 rats and receiving one of the following treatments: (i) control, (ii)10 microgram estradiol (non-protective dose), and (iii) 200 microgram estradiol (protective dose). Each treatment was given in the form of silastic capsule and continued for the length of gestation (3 weeks) in rats. At the end of the treatment, the silastic capsule was removed. The rats were then terminated, 8 and 16 weeks after removal of the hormone treatment. Mammary glands were removed, immediately snap frozen in liquid nitrogen and stored at −80°C. Total RNA and protein were extracted and used for gene and protein expression analyses. Our data indicate that several proteins and genes which are involved in apoptosis, DNA repair and growth inhibition (Bax, Bclaf1, Cidea, Fas, Tnfsf10) are upregulated in the mammary glands of rats that received pregnancy levels of estradiol treatment compared to the rats that received non-pregnancy levels of estradiol treatment and untreated controls. By contrast, there were consistent decreasing levels of proteins and genes involved in growth regulation, angiogenesis, anti-apoptosis and cell cycle regulation (Dad1 Faim, Naip2, Xiap) in the mammary glands of pregnancy level estradiol treated rats when compared to the non pregnancy level estradiol treated rats and untreated controls. These alterations were similar at both the time points after withdrawal of treatments indicating that these changes are constitutive. In conclusion, short-term treatment with pregnancy levels of estradiol resulted in persistent down-regulation of growth promotion, cell cycle, anti-apoptosis, angiogenesis and oncogenesis. On the other hand, the same protective treatment persistently enhanced growth inhibition, apoptosis and DNA repair. The data obtained could be helpful to understand the mechanisms involved in short-term pregnancy level estradiol-induced protection and will also facilitate the identification of biomarkers associated with protection.
Citation Information: Cancer Res 2010;70(24 Suppl):Abstract nr P1-08-01.
Collapse
|
107
|
Van Oosterwijck J, Nijs J, Meeus M, Lefever I, Huybrechts L, Lambrecht L, Paul L. Pain inhibition and postexertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: an experimental study. J Intern Med 2010; 268:265-78. [PMID: 20412374 DOI: 10.1111/j.1365-2796.2010.02228.x] [Citation(s) in RCA: 79] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
OBJECTIVES To examine the efficacy of the pain inhibitory systems in patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) during two different types of exercise and to examine whether the (mal)functioning of pain inhibitory systems is associated with symptom increases following exercise. DESIGN A controlled experimental study. SETTING AND SUBJECTS Twenty-two women with ME/CFS and 22 healthy sedentary controls were studied at the Department of Human Physiology, Vrije Universiteit Brussel. INTERVENTIONS All subjects performed a submaximal exercise test and a self-paced, physiologically limited exercise test on a cycle ergometer. The exercise tests were undertaken with continuous cardiorespiratory monitoring. Before and after the exercise bouts, subjects filled out questionnaires to assess health status, and underwent pressure pain threshold measurements. Throughout the study, subjects' activity levels were assessed using accelerometry. RESULTS In patients with ME/CFS, pain thresholds decreased following both types of exercise, whereas they increased in healthy subjects. This was accompanied by a worsening of the ME/CFS symptom complex post-exercise. Decreased pressure thresholds during submaximal exercise were associated with postexertional fatigue in the ME/CFS group (r = 0.454; P = 0.034). CONCLUSIONS These observations indicate the presence of abnormal central pain processing during exercise in patients with ME/CFS and demonstrate that both submaximal exercise and self-paced, physiologically limited exercise trigger postexertional malaise in these patients. Further study is required to identify specific modes and intensity of exercise that can be performed in people with ME/CFS without exacerbating symptoms.
Collapse
|
108
|
Azar F, Masoori N, Meidani Z, Paul L. Proposal for a modernized Iranian notifiable infectious diseases surveillance system: comparison with USA and Australia. EASTERN MEDITERRANEAN HEALTH JOURNAL 2010. [DOI: 10.26719/2010.16.7.771] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
109
|
Azar FEF, Masoori N, Meidani Z, Paul L. Proposal for a modernized Iranian notifiable infectious diseases surveillance system: comparison with USA and Australia. EASTERN MEDITERRANEAN HEALTH JOURNAL = LA REVUE DE SANTE DE LA MEDITERRANEE ORIENTALE = AL-MAJALLAH AL-SIHHIYAH LI-SHARQ AL-MUTAWASSIT 2010; 16:771-777. [PMID: 20799535] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
Abstract
This article reports on a comparative study of the national notifiable infectious diseases surveillance systems currently employed in the United States of America, Australia and the Islamic Republic of Iran, with the aim ofdeveloping a modified system specific to the needs of the Iranian health system. Features of the surveillance systems examined in each country included: official data gathering structures; types of data collected; case definition and classification criteria; data collection processes; data analysis methods; disease classification systems; data dissemination and distribution methods; data quality control; and confidentiality procedures and guidelines. After consolidating the data, a model for an Iranian notifiable infectious diseases surveillance system was developed and was tested by the Delphi method in 3 stages.
Collapse
|
110
|
Neufeld LM, Mejía‐Rodríguez F, Ponce‐Castañeda MV, Selhub J, Paul L, Cújar C, Hernández A, Orjuela M. Food frequency questionnaires (FFQ) for children under the age of two years: two validation studies. FASEB J 2010. [DOI: 10.1096/fasebj.24.1_supplement.lb314] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
111
|
Nijs J, Van Oosterwijck J, Meeus M, Lambrecht L, Metzger K, Frémont M, Paul L. Unravelling the nature of postexertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: the role of elastase, complement C4a and interleukin-1beta. J Intern Med 2010; 267:418-35. [PMID: 20433584 DOI: 10.1111/j.1365-2796.2009.02178.x] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
OBJECTIVES Too vigorous exercise or activity increase frequently triggers postexertional malaise in people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), a primary characteristic evident in up to 95% of people with ME/CFS. The present study aimed at examining whether two different types of exercise results in changes in health status, circulating elastase activity, interleukin (IL)-1beta and complement C4a levels. DESIGN Comparative experimental design. SETTING University. SUBJECTS Twenty-two women with ME/CFS and 22 healthy sedentary controls INTERVENTIONS participants were subjected to a submaximal exercise (day 8) and a self-paced, physiologically limited exercise (day 16). Each bout of exercise was preceded and followed by blood sampling, actigraphy and assessment of their health status. RESULTS Both submaximal exercise and self-paced, physiologically limited exercise resulted in postexertional malaise in people with ME/CFS. However, neither exercise bout altered elastase activity, IL-1beta or complement C4a split product levels in people with ME/CFS or healthy sedentary control subjects (P > 0.05). Postexercise complement C4a level was identified as a clinically important biomarker for postexertional malaise in people with ME/CFS. CONCLUSIONS Submaximal exercise as well as self-paced, physiologically limited exercise triggers postexertional malaise in people with ME/CFS, but neither types of exercise alter acute circulating levels of IL-1beta, complement C4a split product or elastase activity. Further studying of immune alterations in relation to postexertional malaise in people with ME/CFS using multiple measurement points postexercise is required.
Collapse
|
112
|
Abbasi R, Abdou Y, Abu-Zayyad T, Adams J, Aguilar JA, Ahlers M, Andeen K, Auffenberg J, Bai X, Baker M, Barwick SW, Bay R, Bazo Alba JL, Beattie K, Beatty JJ, Bechet S, Becker JK, Becker KH, Benabderrahmane ML, Berdermann J, Berghaus P, Berley D, Bernardini E, Bertrand D, Besson DZ, Bissok M, Blaufuss E, Boersma DJ, Bohm C, Bolmont J, Botner O, Bradley L, Braun J, Breder D, Carson M, Castermans T, Chirkin D, Christy B, Clem J, Cohen S, Cowen DF, D’Agostino MV, Danninger M, Day CT, De Clercq C, Demirörs L, Depaepe O, Descamps F, Desiati P, de Vries-Uiterweerd G, DeYoung T, Díaz-Vélez JC, Dreyer J, Dumm JP, Duvoort MR, Edwards WR, Ehrlich R, Eisch J, Ellsworth RW, Engdegård O, Euler S, Evenson PA, Fadiran O, Fazely AR, Feusels T, Filimonov K, Finley C, Foerster MM, Fox BD, Franckowiak A, Franke R, Gaisser TK, Gallagher J, Ganugapati R, Gerhardt L, Gladstone L, Goldschmidt A, Goodman JA, Gozzini R, Grant D, Griesel T, Groß A, Grullon S, Gunasingha RM, Gurtner M, Ha C, Hallgren A, Halzen F, Han K, Hanson K, Hasegawa Y, Helbing K, Herquet P, Hickford S, Hill GC, Hoffman KD, Homeier A, Hoshina K, Hubert D, Huelsnitz W, Hülß JP, Hulth PO, Hultqvist K, Hussain S, Imlay RL, Inaba M, Ishihara A, Jacobsen J, Japaridze GS, Johansson H, Joseph JM, Kampert KH, Kappes A, Karg T, Karle A, Kelley JL, Kemming N, Kenny P, Kiryluk J, Kislat F, Klein SR, Knops S, Kohnen G, Kolanoski H, Köpke L, Koskinen DJ, Kowalski M, Kowarik T, Krasberg M, Krings T, Kroll G, Kuehn K, Kuwabara T, Labare M, Lafebre S, Laihem K, Landsman H, Lauer R, Lehmann R, Lennarz D, Lucke A, Lundberg J, Lünemann J, Madsen J, Majumdar P, Maruyama R, Mase K, Matis HS, McParland CP, Meagher K, Merck M, Mészáros P, Meures T, Middell E, Milke N, Miyamoto H, Montaruli T, Morse R, Movit SM, Nahnhauer R, Nam JW, Nießen P, Nygren DR, Odrowski S, Olivas A, Olivo M, Ono M, Panknin S, Patton S, Paul L, Pérez de los Heros C, Petrovic J, Piegsa A, Pieloth D, Pohl AC, Porrata R, Potthoff N, Price PB, Prikockis M, Przybylski GT, Rawlins K, Redl P, Resconi E, Rhode W, Ribordy M, Rizzo A, Rodrigues JP, Roth P, Rothmaier F, Rott C, Roucelle C, Rutledge D, Ruzybayev B, Ryckbosch D, Sander HG, Sarkar S, Schatto K, Schlenstedt S, Schmidt T, Schneider D, Schukraft A, Schulz O, Schunck M, Seckel D, Semburg B, Seo SH, Sestayo Y, Seunarine S, Silvestri A, Slipak A, Spiczak GM, Spiering C, Stamatikos M, Stanev T, Stephens G, Stezelberger T, Stokstad RG, Stoufer MC, Stoyanov S, Strahler EA, Straszheim T, Sulanke KH, Sullivan GW, Swillens Q, Taboada I, Tamburro A, Tarasova O, Tepe A, Ter-Antonyan S, Terranova C, Tilav S, Toale PA, Tooker J, Tosi D, Turčan D, van Eijndhoven N, Vandenbroucke J, Van Overloop A, van Santen J, Voigt B, Walck C, Waldenmaier T, Wallraff M, Walter M, Wendt C, Westerhoff S, Whitehorn N, Wiebe K, Wiebusch CH, Wiedemann A, Wikström G, Williams DR, Wischnewski R, Wissing H, Woschnagg K, Xu C, Xu XW, Yodh G, Yoshida S. Limits on a muon flux from Kaluza-Klein dark matter annihilations in the Sun from the IceCube 22-string detector. Int J Clin Exp Med 2010. [DOI: 10.1103/physrevd.81.057101] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
113
|
Paul L, Schyns P. Attention modulates perceptual asynchrony in binding. J Vis 2010. [DOI: 10.1167/2.7.263] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
114
|
Macgilchrist C, Paul L, Ellis BM, Howe TE, Kennon B, Godwin J. Lower-limb risk factors for falls in people with diabetes mellitus. Diabet Med 2010; 27:162-8. [PMID: 20546259 DOI: 10.1111/j.1464-5491.2009.02914.x] [Citation(s) in RCA: 90] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
BACKGROUND Older people with diabetes mellitus (DM) may be at high risk of falling because of general risk factors for falls as well as disease-specific factors. AIMS To determine the prevalence of falls and to investigate lower-limb factors for falls in older people with DM. Methods Sixty patients with DM over 55 years of age were recruited. 'Fallers' were those who self-reported at least one fall in the previous year. In addition to diabetes status and demographic information, the following were assessed: neuropathy symptom score (NSS), neuropathy disability score (NDS), foot deformity score (FDS), Tinetti performance-oriented assessment of mobility (POMA), ankle muscle strength and gait parameters. Data from 'fallers' and 'non-fallers' were compared and logistic regression analysis performed to identify variables predictive of falls. RESULTS Thirty-five per cent (n = 21) of participants had fallen in the preceding year. Compared with 'non-fallers', there was a greater incidence of peripheral neuropathy among 'fallers' (86% of 'fallers' and 56% of 'non-fallers'), higher vibration perception threshold (P = 0.04), slower gait velocity (P < 0.001), lower muscle strength for dorsiflexion, plantarflexion, inversion and eversion (all P < 0.001) and higher incidence of bony prominences and prominent metatarsal heads (both P < 0.001). There was a strong and significant correlation between dorsiflexion muscle strength and gait velocity. Logistic regression analysis determined that walking velocity, strength of ankle dorsiflexors and NSS accurately predicted 75% of 'fallers'. CONCLUSIONS Simple clinical measures of gait velocity and ankle muscle strength may be used to identify people with DM at risk of falling, allowing preventative strategies to be implemented.
Collapse
|
115
|
Abbasi R, Abdou Y, Abu-Zayyad T, Adams J, Aguilar JA, Ahlers M, Andeen K, Auffenberg J, Bai X, Baker M, Barwick SW, Bay R, Bazo Alba JL, Beattie K, Beatty JJ, Bechet S, Becker JK, Becker KH, Benabderrahmane ML, Berdermann J, Berghaus P, Berley D, Bernardini E, Bertrand D, Besson DZ, Bissok M, Blaufuss E, Boersma DJ, Bohm C, Botner O, Bradley L, Braun J, Breder D, Carson M, Castermans T, Chirkin D, Christy B, Clem J, Cohen S, Cowen DF, D'Agostino MV, Danninger M, Day CT, De Clercq C, Demirörs L, Depaepe O, Descamps F, Desiati P, de Vries-Uiterweerd G, DeYoung T, Díaz-Vélez JC, Dreyer J, Dumm JP, Duvoort MR, Edwards WR, Ehrlich R, Eisch J, Ellsworth RW, Engdegård O, Euler S, Evenson PA, Fadiran O, Fazely AR, Feusels T, Filimonov K, Finley C, Foerster MM, Fox BD, Franckowiak A, Franke R, Gaisser TK, Gallagher J, Ganugapati R, Gerhardt L, Gladstone L, Goldschmidt A, Goodman JA, Gozzini R, Grant D, Griesel T, Gross A, Grullon S, Gunasingha RM, Gurtner M, Ha C, Hallgren A, Halzen F, Han K, Hanson K, Hasegawa Y, Helbing K, Herquet P, Hickford S, Hill GC, Hoffman KD, Homeier A, Hoshina K, Hubert D, Huelsnitz W, Hülss JP, Hulth PO, Hultqvist K, Hussain S, Imlay RL, Inaba M, Ishihara A, Jacobsen J, Japaridze GS, Johansson H, Joseph JM, Kampert KH, Kappes A, Karg T, Karle A, Kelley JL, Kemming N, Kenny P, Kiryluk J, Kislat F, Klein SR, Knops S, Kohnen G, Kolanoski H, Köpke L, Koskinen DJ, Kowalski M, Kowarik T, Krasberg M, Krings T, Kroll G, Kuehn K, Kuwabara T, Labare M, Lafebre S, Laihem K, Landsman H, Lauer R, Lehmann R, Lennarz D, Lundberg J, Lünemann J, Madsen J, Majumdar P, Maruyama R, Mase K, Matis HS, McParland CP, Meagher K, Merck M, Mészáros P, Meures T, Middell E, Milke N, Miyamoto H, Montaruli T, Morse R, Movit SM, Nahnhauer R, Nam JW, Niessen P, Nygren DR, Odrowski S, Olivas A, Olivo M, Ono M, Panknin S, Patton S, Paul L, Pérez de los Heros C, Petrovic J, Piegsa A, Pieloth D, Pohl AC, Porrata R, Potthoff N, Price PB, Prikockis M, Przybylski GT, Rawlins K, Redl P, Resconi E, Rhode W, Ribordy M, Rizzo A, Rodrigues JP, Roth P, Rothmaier F, Rott C, Roucelle C, Rutledge D, Ruzybayev B, Ryckbosch D, Sander HG, Sarkar S, Schatto K, Schlenstedt S, Schmidt T, Schneider D, Schukraft A, Schulz O, Schunck M, Seckel D, Semburg B, Seo SH, Sestayo Y, Seunarine S, Silvestri A, Slipak A, Spiczak GM, Spiering C, Stamatikos M, Stanev T, Stephens G, Stezelberger T, Stokstad RG, Stoufer MC, Stoyanov S, Strahler EA, Straszheim T, Sullivan GW, Swillens Q, Taboada I, Tamburro A, Tarasova O, Tepe A, Ter-Antonyan S, Terranova C, Tilav S, Toale PA, Tooker J, Tosi D, Turcan D, van Eijndhoven N, Vandenbroucke J, Van Overloop A, van Santen J, Voigt B, Walck C, Waldenmaier T, Wallraff M, Walter M, Wendt C, Westerhoff S, Whitehorn N, Wiebe K, Wiebusch CH, Wiedemann A, Wikström G, Williams DR, Wischnewski R, Wissing H, Woschnagg K, Xu C, Xu XW, Yodh G, Yoshida S. Extending the search for neutrino point sources with IceCube above the horizon. PHYSICAL REVIEW LETTERS 2009; 103:221102. [PMID: 20366087 DOI: 10.1103/physrevlett.103.221102] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/09/2009] [Indexed: 05/29/2023]
Abstract
Point source searches with the IceCube neutrino telescope have been restricted to one hemisphere, due to the exclusive selection of upward going events as a way of rejecting the atmospheric muon background. We show that the region above the horizon can be included by suppressing the background through energy-sensitive cuts. This improves the sensitivity above PeV energies, previously not accessible for declinations of more than a few degrees below the horizon due to the absorption of neutrinos in Earth. We present results based on data collected with 22 strings of IceCube, extending its field of view and energy reach for point source searches. No significant excess above the atmospheric background is observed in a sky scan and in tests of source candidates. Upper limits are reported, which for the first time cover point sources in the southern sky up to EeV energies.
Collapse
|
116
|
Hamilton F, Rochester L, Paul L, Rafferty D, O'Leary CP, Evans JJ. Walking and talking: an investigation of cognitive-motor dual tasking in multiple sclerosis. Mult Scler 2009; 15:1215-27. [PMID: 19667011 DOI: 10.1177/1352458509106712] [Citation(s) in RCA: 134] [Impact Index Per Article: 8.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
BACKGROUND Deficits in motor functioning, including walking, and in cognitive functions, including attention, are known to be prevalent in multiple sclerosis (MS), though little attention has been paid to how impairments in these areas of functioning interact. OBJECTIVES This study investigated the effects of performing a concurrent cognitive task when walking in people with MS. Level of task demand was manipulated to investigate whether this affected level of dual-task decrement. METHOD Eighteen participants with MS and 18 healthy controls took part. Participants completed walking and cognitive tasks under single- and dual-task conditions. RESULTS Compared to healthy controls, MS participants showed greater decrements in performance under dual-task conditions in cognitive task performance, walking speed and swing time variability. In the MS group, the degree of decrement under dual-task conditions was related to levels of fatigue, a measure of general cognitive functioning and self-reported everyday cognitive errors, but not to measures of disease severity or duration. CONCLUSIONS Difficulty with walking and talking in MS may be a result of a divided attention deficit or of overloading of the working memory system, and further investigation is needed. We suggest that difficulty with walking and talking in MS may lead to practical problems in everyday life, including potentially increasing the risk of falls. Clinical tools to assess cognitive-motor dual-tasking ability are needed.
Collapse
|
117
|
Paul L, Cattaneo M, D'Angelo A, Sampietro F, Fermo I, Razzari C, Fontana G, Eugene N, Jacques PF, Selhub J. Telomere length in peripheral blood mononuclear cells is associated with folate status in men. J Nutr 2009; 139:1273-8. [PMID: 19458030 DOI: 10.3945/jn.109.104984] [Citation(s) in RCA: 55] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023] Open
Abstract
Human chromosomes are capped by telomeres, which consist of tandem repeats of DNA and associated proteins. The length of the telomeres is reduced with increasing cell divisions except when the enzyme telomerase is active, as in stem cells and germ cells. Telomere dysfunction has been associated with development of age-related pathologies, including cancer, cardiovascular disease, Alzheimer's disease, and Parkinson's disease. DNA damage in the telomeric region causes attrition of telomeres. Because folate provides precursors for nucleotide synthesis and thus affects the integrity of DNA, including that of the telomeric region, folate status has the potential to influence telomere length. Telomere length is epigenetically regulated by DNA methylation, which in turn could be modulated by folate status. In this study, we determined whether folate status and the 677C > T polymorphism of the methylene tetrahydrofolate reductase (MTHFR) gene are associated with the telomere length of peripheral blood mononuclear cells in healthy men. The results of our study showed that plasma concentration of folate was associated with telomere length of peripheral blood mononuclear cells in a nonlinear manner. When plasma folate concentration was above the median, there was a positive relationship between folate and telomere length. In contrast, there was an inverse relationship between folate and telomere length when plasma folate concentration was below the median. The MTHFR 677C > T polymorphism was weakly associated (P = 0.065) with increased telomere length at below-median folate status. We propose that folate status influences telomere length by affecting DNA integrity and the epigenetic regulation of telomere length through DNA methylation.
Collapse
|
118
|
Schyns F, Paul L, Finlay K, Ferguson C, Noble E. Vibration therapy in multiple sclerosis: a pilot study exploring its effects on tone, muscle force, sensation and functional performance. Clin Rehabil 2009; 23:771-81. [DOI: 10.1177/0269215508101758] [Citation(s) in RCA: 68] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Objective: To examine the effectiveness of whole body vibration (WBV) on tone, muscle force, sensation and functional performance in people with multiple sclerosis. Design: A randomized cross-over pilot study. Setting: Revive MS Support Therapy Centre. Glasgow, UK. Subjects: Sixteen people with multiple sclerosis were randomly allocated to one of two groups. Intervention: Group 1 received four weeks of whole body vibration plus exercise three times per week, two weeks of no intervention and then four weeks of exercise alone three times per week. Group 2 were given the two treatment interventions in the reverse order to group 1. Main measures: Ten-metre walk, Timed Up and Go Test, Modified Ashworth Scale, Multiple Sclerosis Spasticity Scale (MSSS-88), lower limb muscle force, Nottingham Sensory Assessment and Multiple Sclerosis Impact Scale (MSIS-29) were used before and after intervention. Results: The exercise programme had positive effects on muscle force and well-being, but there was insufficient evidence that the addition of whole body vibration provided any further benefit. The Modified Ashworth Scale was generally unaffected by either intervention, although, for each group, results from the MSSS-88 showed whole body vibration and exercises reduced muscle spasms (P = 0.02). Although results for the 10-m walk and Timed Up and Go Test improved, this did not reach statistical significance (P = 0.56; P = 0.70, respectively). For most subjects sensation was unaffected by whole body vibration. Conclusion: Exercise may be beneficial to those with multiple sclerosis, but there is limited evidence that the addition of whole body vibration provides any additional improvements. Further larger scale studies into the effects of whole body vibration in people with multiple sclerosis are essential.
Collapse
|
119
|
Paul L, Ellis BM, Leese GP, McFadyen AK, McMurray B. The effect of a cognitive or motor task on gait parameters of diabetic patients, with and without neuropathy. Diabet Med 2009; 26:234-9. [PMID: 19317817 DOI: 10.1111/j.1464-5491.2008.02655.x] [Citation(s) in RCA: 52] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
AIMS To compare gait parameters of older people with diabetes and no peripheral neuropathy (DM) and people with diabetes and diabetic peripheral neuropathy (DPN) and to investigate the effect of a secondary motor or cognitive task on their gait. METHODS Thirty subjects were recruited: 15 with DPN (mean age 69 +/- 3.0 years) and 15 with diabetes and no neuropathy (70 +/- 2.9 years). The temporal and spatial parameters of gait were determined using the GAITRite walkway. Subjects undertook four walks: under normal walking conditions (single task); four times while simultaneously undertaking an additional motor task, carrying a tray with cups of water (dual task); and four times whilst undertaking a cognitive dual task, counting backwards in sevens. This arithmetic task was also completed sitting. RESULTS For all gait variables, there was a statistically significant difference between the groups. Subjects with DPN walked more slowly and with smaller steps compared with those with DM. In general, the secondary task had a significant and adverse effect on the gait parameters and this effect was greater for those with DPN in both absolute and relative terms. Both groups had poorer arithmetic ability when walking compared with sitting. DISCUSSION Patients with DPN have different gait parameters to diabetic patients without neuropathy. Problems with divided attention when walking were more evident in the DPN group and may increase their risk of falls.
Collapse
|
120
|
Gawkrodger DJ, Paul L. Late patch test reactions: delayed immune response appears to be more common than active sensitization. Contact Dermatitis 2008; 59:185-7. [PMID: 18759909 DOI: 10.1111/j.1600-0536.2008.01396.x] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
121
|
Rammling M, Madan M, Paul L, Behnam B, Pattisapu J. O.111 Intranasal curcumin to improve olfactory CSF pathways – Preliminary findings. Clin Neurol Neurosurg 2008. [DOI: 10.1016/s0303-8467(08)70116-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
122
|
Paul L, Behnam B, Madan M, Rammling M, Pattisapu J. O.112 Vinpocetine as a modulator of Aquaporin 1 and 4. Clin Neurol Neurosurg 2008. [DOI: 10.1016/s0303-8467(08)70117-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
123
|
Paul L, Rafferty D, Young S, Miller L, Mattison P, McFadyen A. The effect of functional electrical stimulation on the physiological cost of gait in people with multiple sclerosis. Mult Scler 2008; 14:954-61. [PMID: 18573839 DOI: 10.1177/1352458508090667] [Citation(s) in RCA: 47] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
OBJECTIVE Functional electrical stimulation (FES) is used clinically in the management of drop foot in people suffering from neurological conditions. The aim of the study was to investigate the effects of FES, in terms of speed and physiological cost of gait, in people with multiple sclerosis (pwMS). METHODS Twelve pwMS and 12 healthy matched controls walked at their own preferred walking speed (PWS) for 5 min around a 10 m elliptical course. Subjects with MS completed the protocol with and without using their FES. In addition, control subjects completed the protocol twice more walking at the same PWS of the pwMS to which they were matched. RESULTS Wearing FES lead to a significant improvement in walking speed (0.49 ms(-1) and 0.43 ms(-1) with and without their FES respectively; P<0.001) and a significant reduction in the physiological cost of gait (0.41 mL min(-1) kg(-1) m(-1) and 0.46 mL min(-1) kg(-1) m(-1) with and without FES respectively; P=0.017) in pwMS. The speed of walking, oxygen uptake, and physiological cost were significantly different between pwMS and controls both at preferred and matched speeds. Although pwMS exhibit a higher physiological cost of walking, FES offers an orthotic benefit to pwMS and should be considered as a possible treatment option.
Collapse
|
124
|
Miller L, Mattison P, Paul L, Wood L. The effects of transcutaneous electrical nerve stimulation (TENS) on spasticity in multiple sclerosis. Mult Scler 2007; 13:527-33. [PMID: 17463075 DOI: 10.1177/1352458506071509] [Citation(s) in RCA: 47] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Spasticity is a common and often disabling symptom associated with multiple sclerosis (MS). Transcutaneous electrical nerve stimulation (TENS) has been found effective in reducing spasticity in conditions such as stroke, but there is little evidence to support its use in MS. The aim of this study was to evaluate the effectiveness of TENS on spasticity in MS and, furthermore, to compare two different application times. Thirty-two subjects were randomized into two groups, and a single, blind, crossover design was used to compare two weeks of 60 minutes and 8 hours daily of TENS applications (100 Hz and 0.125 ms pulse width). Outcomes were examined using the Global Spasticity Score (GSS), the Penn Spasm Score (PSS), and a visual analogue scale (VAS) for pain. The results of the study demonstrated that there were no statistically significant differences in the GSS following either 60 minutes or 8 hours daily of TENS (P=0.433 and 0.217, respectively). The 8-hour application time led to a significant reduction in muscle spasm (P=0.038) and pain (P = 0.008). Thus, this study suggests that, whilst TENS does not appear to be effective in reducing spasticity, longer applications may be useful in treating MS patients with pain and muscle spasm. Multiple Sclerosis 2007; 13: 527-533. http://msj.sagepub.com
Collapse
|
125
|
Muniswamy H, Dutcher JP, Mannam P, Malik S, Rusciano V, Paul L, Wiernik PH. Role of prognostic factors in patients with metastatic renal cell carcinoma (MRCC) eligible for treatment with interleukin (IL2). J Clin Oncol 2006. [DOI: 10.1200/jco.2006.24.18_suppl.14514] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
14514 Background: Motzer (JCO1999) defined 5 factors that predict for poor survival of patients with MRCC: low Karnofsky scale (<80%), high LDH (>1.5 times upper limit), low Hb (<lower limit of normal), elevated corrected calcium (10 mg/dl) and absence of nephrectomy. Method: We retrospectively evaluated 124 patients with MRCC (81 male/43 female, median age 54 years, range (R) 27 to 79 years) treated in our center from 10/98–12/05 with IL2 based therapy. Patients eligible for IL2 study were included. Patients were categorized into favorable (F - 0 risk factors), intermediate (I - 1–2 risk factors) and poor (P - 3 or more risk factors) groups. 89 patients had high dose (HD) IL2 (600,000 u/kg/dose every 8 hours up to 14 doses), and 35 patients had moderate dose (MD) IL2 (5 mu/m2/day for 5 days continuous infusion or 72,000 u/kg every 8h up to 14 doses). 26 patients had prior treatment. Prognostic factors were identified at the start of IL2 therapy. Primary endpoint was survival time defined as the time from initiation of IL2 treatment to time of death or December 2005 as the last follow up for all patients. Results: Analyzed using Kaplan-Meier method. Conclusions: 1. These prognostic factors apply to IL2 treated patients and separate them into prognostic groups. 2. HD IL2 treated patients have ≥ 6 months greater survival compared to MD IL2 treated patients or historical data. [Table: see text] No significant financial relationships to disclose.
Collapse
|